Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice
Wenli Zhu(Guangzhou University of Chinese Medicine), Shijie Zhang(Jiangnan University), Yi Luo(Kunming Institute of Botany), Huafeng Pan(Guangzhou University of Chinese Medicine), Hao-Fei Liu(Guangzhou University of Chinese Medicine), Wei-Wu Cai(Guangzhou University of Chinese Medicine), Qi Wang(Hebei Medical University), Hong Wang(Nanjing Forestry University), Xiaoqi Liu(University of Kentucky), Jiayi Zheng(Guangzhou University of Chinese Medicine), Tingting Xu(Guangzhou University of Chinese Medicine), Su-Fen Wei(Guangzhou University of Chinese Medicine), Zhao Dai(Guangzhou University of Chinese Medicine), Benyue Li(Guangzhou University of Chinese Medicine)
Cited by 66
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease
|Journal of Structural Biology|2005|585
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
|Annals of Oncology|2015|467
Heritability and genomics of gene expression in peripheral blood
|Nature Genetics|2014|424